Abstract
The structure of the title compound has been determined from diffractometer data recorded, initially, at 294 K and, subsequently, at 168 K. Crystals are triclinic, space group P1 with (168 K values in square brackets) a 16.080(2) [15.934(2)], b 15.958(2) [15.880(2)], c 8.443(2)Ǻ [8.233(1)Ǻ], α 85.55(1) [86.04(1)],β 82.65(1) [82.56(1)],γ 85.00(1)° [84.73(1)°], and contain two actamycin and two solvent ( tetrahydrofuran ) molecules in the asymmetric scattering unit. The structure was solved with DIRDIF and refined by block-diagonal least-squares analysis (of 168 K data) to R 0.049 ( wR 0.069) for 5640 reflections and 940 refined parameters. Molecules of actamycin (30-dechloro-2-demethyl-30-hydroxynaphthomycin A) exhibit the same relative stereochemistry (8S*,9S*,15S*,18S*,19S*,20S*) and double-bond configuration (2Z,4Z,6E,12E,16E,21E) as reported for crystalline 25-O-methylnaphthomycin A iminomethyl ether but are quite differently conformed. The two crystallographically inequivalent actamycin molecules in the present structure also exhibit substantial conformational (torsion angle) differences due, apparently, to the effects of intermolecular hydrogen bonding. Consideration of chiroptical data defines the absolute configuration of actamycin as 8S,9S,15S,18S,19S,20S and the helicity as P, as in naphthomycin A.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.